Optimal schedule of adjuvant chemotherapy with S-1 for stage III colon cancer: study protocol for a randomized controlled trial

BACKGROUND: Although, in Western countries, oxaliplatin-based regimens have been established as a gold standard treatment for patients with stage III or high risk stage II colon cancer after curative resection, in Japan fluorouracil-based regimens have been widely accepted and recommended in the gui...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshimura, Kenichi, Uehara, Keisuke, Tojima, Yuichiro, Kawai, Satoru, Mokuno, Yasuji, Maeda, Atsuyuki, Kyokane, Takanori, Kobayashi, Satoshi, Yoshioka, Yuichiro, Nagino, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564899/
https://www.ncbi.nlm.nih.gov/pubmed/23320901
http://dx.doi.org/10.1186/1745-6215-14-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564899/
https://www.ncbi.nlm.nih.gov/pubmed/23320901
http://dx.doi.org/10.1186/1745-6215-14-17

Ejemplares similares